ReproCELL: Announcement regarding the large exercise of the 16th subscription rights (with exercise price adjustment clause and exercise permission clause).
ReproCELL: Announcement regarding the large exercise of the 16th subscription rights (with exercise price adjustment clause and exercise permission clause).
ReproCELL: Announcements of individual stocks regarding the start of providing regenerative medical grade iPS exosomes with JTB Co., Ltd.
ReproCELL: Announcements of individual stocks regarding the decision to grant subsidies to the subsidiary (REPROCELL USA Inc.).
ReproCELL: Announcements of individual stocks regarding the monthly exercise status of the 16th subscription rights (with exercise price adjustment and exercise permission clauses).
ReproCELL: Matters related to business plans and growth potential.
ReproCELL: Announcements of individual stocks regarding the decision to grant subsidies to the subsidiary (REPROCELL USA Inc.).
ReproCELL: Articles of Incorporation: June 24, 2024
ReproCELL: Announcements of individual stocks related to personnel changes.
ReproCELL: Notice regarding the monthly exercise status of the 16th Stock Acquisition Rights (with exercise price amendment clauses and exercise permission clauses)
ReproCELL: Notice Concerning Decrease in Capital Reserve Amount and Disposal of Surplus Funds
ReproCELL: Notice regarding transfer of certified public accountants, etc.
ReproCELL: Notice regarding subsidies to consolidated subsidiaries (REPROCELL USA Inc.)
ReproCELL: Notice regarding the monthly exercise status of the 16th Stock Acquisition Rights (with exercise price amendment clauses and exercise permission clauses)
ReproCELL: Partial correction to “Notice of patent registration in Japan relating to treatment of polyglutamine disease by Steminent”
ReproCELL: Notice of patent registration in Japan relating to treatment of polyglutamine disease by Steminent
ReproCELL: Notice regarding adoption of the AMED public offering project “Basic Technology Development Project for Industrialization of Regenerative Medicine and Gene Therapy”
Reprocel: Notice regarding the monthly exercise status of the 16th Stock Acquisition Rights (with exercise price amendment clauses and exercise permission clauses)
Reprocel: Notice regarding listing of the investor Stemminent on the Taiwan Emerging Stock Board
Reprocel: Notice regarding the monthly exercise status of the 16th Stock Acquisition Rights (with exercise price amendment clauses and exercise permission clauses)
No Data